Article
Robust eIF4B levels undermine invasive growth and immune evasion mechanisms in murine…
medRxiv · 2022 · Randall Smith Jr.
Key facts
| Title | Robust eIF4B levels undermine invasive growth and immune evasion mechanisms in murine triple negative breast cancer models. |
|---|---|
| First author | Randall Smith Jr. |
| Journal | medRxiv |
| Published | Sep 18, 2022 |
| DOI | 10.1101/2022.09.16.508318 |
| Devices mentioned | BK110039, DEN000008, K022086 |
| Product codes mentioned | JCI, KIT, NDS, NJT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1